Jump to content

Category:Pharmacogenomic phenotypes: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 May 2026

20 May 2026

  • curprev 18:5518:55, 20 May 2026 MDElliottMD talk contribs 11,842 bytes +1,303 Add CYP3A4 to the indexed phenotype list (3 pages: PM/IM/NM) and add a lead paragraph on the CPIC/DPWG disagreement over whether CYP3A4 warrants a phenotype scheme. Per parser-claude 2026-05-20 source check confirming the DPWG CYP3A4 framework is valid. Category now indexes 29 phenotype pages across 8 genes.
  • curprev 00:3200:32, 20 May 2026 MDElliottMD talk contribs 10,539 bytes +10,539 Create Category:Pharmacogenomic phenotypes per the canonical category-page spec: descriptive history-first lead (the debrisoquine polymorphism, Smith at St Mary's London 1977, Mahgoub 1977 PMID 71400, origin of the poor/extensive metabolizer vocabulary; Weinshilboum 1980 TPMT PMID 7191632; the genotype-to-phenotype harmonisation Caudle 2020 PMID 31647186). Phenotypes-indexed list grouped by gene (26 pages). Notes on scope, About-these-pages, references. Carries Category:Pharmacogenomics paren...
Retrieved from "https://pharmacopedia.wiki/p/Category:Pharmacogenomic_phenotypes"